Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.
Arctic Therapeutics has raised $27.5M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Arctic Therapeutics's investors include European Innovation Council, EIC Accelerator, Sanos Clinic, Nancy Lurie Marks Family Foundation, Cerebrum DAO.
Arctic Therapeutics is headquartered in Reykjavík, Iceland.
Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.
Arctic Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arctic Therapeutics — Funding & Investors." VCBacked, January 21, 2025, https://www.vcbacked.co/company/arctic-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Arctic Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/arctic-therapeutics
{{cite web |title=Arctic Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/arctic-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated